Trial Profile
Clinical study about the hypotensive effect and the inhibitory effect on the elevatin of uric acid level irbesartan and trichlormethiazide in the essential hypertension patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Irbesartan/trichlormethiazide (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 06 Jun 2016 New trial record